Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60.5M
-
Number of holders
-
191
-
Total 13F shares, excl. options
-
59.1M
-
Shares change
-
+8.08M
-
Total reported value, excl. options
-
$2.91B
-
Value change
-
+$350M
-
Put/Call ratio
-
1.19
-
Number of buys
-
115
-
Number of sells
-
-86
-
Price
-
$49.38
Significant Holders of Twist Bioscience Corp - Common Stock (TWST) as of Q1 2022
252 filings reported holding TWST - Twist Bioscience Corp - Common Stock as of Q1 2022.
Twist Bioscience Corp - Common Stock (TWST) has 191 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 59.1M shares
of 60.5M outstanding shares and own 97.73% of the company stock.
Largest 10 shareholders include FMR LLC (6.63M shares), ARK Investment Management LLC (5.26M shares), Capital World Investors (4.8M shares), VANGUARD GROUP INC (4.79M shares), BlackRock Inc. (4.69M shares), Jackson Square Partners, LLC (2.5M shares), STATE STREET CORP (2.48M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.38M shares), Nikko Asset Management Americas, Inc. (2.38M shares), and JPMORGAN CHASE & CO (2.11M shares).
This table shows the top 191 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.